Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle’s AI Ambition: A High-Stakes Infrastructure Gamble

Felix Baarz by Felix Baarz
December 2, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software
0
Oracle Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

Oracle shares are approaching a critical juncture. As the stock price has recently shown weakness, a colossal infrastructure deal taking shape behind the scenes could redefine the company’s role in powering the next generation of artificial intelligence. Market experts point to a potential upside nearing 90%, yet investor apprehension over the associated capital expenditure remains palpable.

A Pivotal Earnings Report on the Horizon

The immediate focus for investors is Oracle’s upcoming quarterly results. The financial report for the second quarter, scheduled for release on Monday, December 8, is widely anticipated. A strong performance or, crucially, an official confirmation of a landmark partnership could serve as the catalyst to narrow the significant gap between the current share price and analyst price targets. Presently, the equity trades around €174.56, a level substantially below its previous peaks.

The $38 Billion OpenAI Partnership

Central to Oracle’s strategic shift is a reported financing package of staggering proportions. The company, in collaboration with Vantage Data Centers, is reportedly in negotiations to invest approximately $38 billion to construct new data centers specifically designed for OpenAI, the creator of ChatGPT. This initiative would rank among the largest infrastructure commitments in the industry’s history.

The move underscores a deliberate and aggressive strategy to transform Oracle’s identity. The goal is to shed its legacy image as a traditional software enterprise and establish itself as an indispensable backbone for generative AI. Should this agreement be finalized, the capital infusion would supplement the already-secured $30 billion in funding provided by partners such as SoftBank.

Should investors sell immediately? Or is it worth buying Oracle?

Analysts Identify Significant Undervaluation

Despite these ambitious plans, the market’s valuation has left analysts from Deutsche Bank and HSBC perplexed. Both institutions have reaffirmed their price targets exceeding $375 per share. Their core thesis is that the burgeoning revenue stream from the OpenAI business is currently being assigned virtually no value by the market.

Experts Brad Zelnick of Deutsche Bank and Stephen Bersey of HSBC argue that even excluding potential income from this partnership, Oracle’s core business justifies a higher valuation. They see the present stock level as a clear mispricing that fails to account for the company’s long-term growth drivers.

Investor Jitters Over “AI Waste”

The disconnect between analyst optimism and market sentiment stems from concerns over capital allocation. A key hesitation among investors revolves around the fear of “AI waste” and the specter of exploding investment costs. The potential need for Oracle to take on substantial debt to fund the $38 billion project has prompted worries about balance sheet strain among more conservative market participants.

This caution persists even though Oracle’s stock, with a forward P/E ratio just under 30, appears moderately valued both from a historical perspective and when compared to other high-flying AI-centric companies. The coming days will determine whether the bullish outlook prevails, hinging on concrete financial results and strategic clarity from the company’s leadership.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from February 7 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
MP Materials Stock

MP Materials Stock Faces Mounting Pressure from Institutional and Insider Selling

ASML Stock

ASML Shares Surge to New Highs Amid Conflicting Market Forces

Fidelity National Information Services Stock

Fidelity National Information Services: Is a Major Rally on the Horizon?

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com